Researchers explore the medicinal role of curcumin in the treatment and prevention of neuroinflammation and metabolic ...

DelveInsight’s "Rheumatoid Arthritis Market Insights, Epidemiology, and Market Forecast – 2034" report delivers an in-depth ...

Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...

She’d been injecting herself for years, and just gotten into trouble," says Dr. Kontis, explaining that the patient’s needle ...

Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth -- ARCALYST 2025 expected net product revenue increased to $590 - $605 million -- KPL-387 Phase 2/3 clinical trial ...

The name Brett Favre brings up two different memories in the minds of football fans. On one hand, he was one of the best ever ...

DelveInsight’s “Ulcerative Colitis Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...